FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1120017812> ?p ?o ?g. }

• W1120017812 endingPage "518" @default.
• W1120017812 startingPage "512" @default.
• W1120017812 abstract "Dengue is a mosquito-borne viral disease that is endemic in India. We evaluated the immunogenicity and safety of recombinant, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in Indian adults. In this observer-blind, randomized, placebo-controlled, Phase II study, adults aged 18-45 years were randomized 2:1 to receive CYD-TDV or placebo at 0, 6 and 12 months in sub-cutaneous administration. Immunogenicity was assessed using a 50% plaque reduction neutralization test (PRNT50) at baseline and 28 days after each study injection. 189 participants were enrolled (CYD-TDV [n = 128]; placebo, [n = 61]). At baseline, seropositivity rates for dengue serotypes 1, 2, 3 and 4 ranged from 77.0% to 86.9%. Seropositivity rates for each serotype increased after each CYD-TDV injection with a more pronounced increase after the first injection. In the CYD-TDV group, geometric mean titres (GMTs) were 2.38 to 6.11-fold higher after the third injection compared with baseline but remained similar to baseline in the placebo group. In the CYD-TDV group, the GMTs were 1.66 to 4.95-fold higher and 9.23 to 24.6-fold higher after the third injection compared with baseline in those who were dengue seropositive and dengue seronegative, respectively. Pain was the most commonly reported solicited injection site reaction after the first injection in both the CYD-TDV (6.3%) and placebo groups (4.9%), but occurred less frequently after subsequent injections. No serious adverse events were vaccine-related, no immediate unsolicited adverse events, and no virologically-confirmed cases of dengue, were reported during the study. The immunogenicity and safety of CYD-TDV was satisfactory in both dengue seropositive and seronegative Indian adults." @default.
• W1120017812 created "2016-06-24" @default.
• W1120017812 creator A5004733473 @default.
• W1120017812 creator A5015954272 @default.
• W1120017812 creator A5038262133 @default.
• W1120017812 creator A5038402743 @default.
• W1120017812 creator A5049648266 @default.
• W1120017812 creator A5070209591 @default.
• W1120017812 creator A5075669592 @default.
• W1120017812 creator A5089026604 @default.
• W1120017812 date "2015-08-20" @default.
• W1120017812 modified "2023-09-25" @default.
• W1120017812 title "Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial" @default.
• W1120017812 cites W1143620379 @default.
• W1120017812 cites W1970660384 @default.
• W1120017812 cites W1987755123 @default.
• W1120017812 cites W1989767365 @default.
• W1120017812 cites W1996416492 @default.
• W1120017812 cites W2029371930 @default.
• W1120017812 cites W2030142520 @default.
• W1120017812 cites W2077326785 @default.
• W1120017812 cites W2079742755 @default.
• W1120017812 cites W2097288560 @default.
• W1120017812 cites W2099814026 @default.
• W1120017812 cites W2100675371 @default.
• W1120017812 cites W2111222009 @default.
• W1120017812 cites W2113357526 @default.
• W1120017812 cites W2116471574 @default.
• W1120017812 cites W2131222241 @default.
• W1120017812 cites W2133598290 @default.
• W1120017812 cites W2153873757 @default.
• W1120017812 cites W2156783779 @default.
• W1120017812 cites W2164079841 @default.
• W1120017812 doi "https://doi.org/10.1080/21645515.2015.1076598" @default.
• W1120017812 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5049724" @default.
• W1120017812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26291554" @default.
• W1120017812 hasPublicationYear "2015" @default.
• W1120017812 type Work @default.
• W1120017812 sameAs 1120017812 @default.
• W1120017812 citedByCount "20" @default.
• W1120017812 countsByYear W11200178122016 @default.
• W1120017812 countsByYear W11200178122017 @default.
• W1120017812 countsByYear W11200178122018 @default.
• W1120017812 countsByYear W11200178122019 @default.
• W1120017812 countsByYear W11200178122020 @default.
• W1120017812 countsByYear W11200178122021 @default.
• W1120017812 countsByYear W11200178122022 @default.
• W1120017812 countsByYear W11200178122023 @default.
• W1120017812 crossrefType "journal-article" @default.
• W1120017812 hasAuthorship W1120017812A5004733473 @default.
• W1120017812 hasAuthorship W1120017812A5015954272 @default.
• W1120017812 hasAuthorship W1120017812A5038262133 @default.
• W1120017812 hasAuthorship W1120017812A5038402743 @default.
• W1120017812 hasAuthorship W1120017812A5049648266 @default.
• W1120017812 hasAuthorship W1120017812A5070209591 @default.
• W1120017812 hasAuthorship W1120017812A5075669592 @default.
• W1120017812 hasAuthorship W1120017812A5089026604 @default.
• W1120017812 hasBestOaLocation W11200178121 @default.
• W1120017812 hasConcept C126322002 @default.
• W1120017812 hasConcept C138894074 @default.
• W1120017812 hasConcept C142724271 @default.
• W1120017812 hasConcept C159654299 @default.
• W1120017812 hasConcept C168563851 @default.
• W1120017812 hasConcept C197934379 @default.
• W1120017812 hasConcept C203014093 @default.
• W1120017812 hasConcept C204787440 @default.
• W1120017812 hasConcept C27081682 @default.
• W1120017812 hasConcept C2779308166 @default.
• W1120017812 hasConcept C2779635636 @default.
• W1120017812 hasConcept C2780868878 @default.
• W1120017812 hasConcept C45189115 @default.
• W1120017812 hasConcept C533803919 @default.
• W1120017812 hasConcept C71924100 @default.
• W1120017812 hasConceptScore W1120017812C126322002 @default.
• W1120017812 hasConceptScore W1120017812C138894074 @default.
• W1120017812 hasConceptScore W1120017812C142724271 @default.
• W1120017812 hasConceptScore W1120017812C159654299 @default.
• W1120017812 hasConceptScore W1120017812C168563851 @default.
• W1120017812 hasConceptScore W1120017812C197934379 @default.
• W1120017812 hasConceptScore W1120017812C203014093 @default.
• W1120017812 hasConceptScore W1120017812C204787440 @default.
• W1120017812 hasConceptScore W1120017812C27081682 @default.
• W1120017812 hasConceptScore W1120017812C2779308166 @default.
• W1120017812 hasConceptScore W1120017812C2779635636 @default.
• W1120017812 hasConceptScore W1120017812C2780868878 @default.
• W1120017812 hasConceptScore W1120017812C45189115 @default.
• W1120017812 hasConceptScore W1120017812C533803919 @default.
• W1120017812 hasConceptScore W1120017812C71924100 @default.
• W1120017812 hasIssue "2" @default.
• W1120017812 hasLocation W11200178121 @default.
• W1120017812 hasLocation W11200178122 @default.
• W1120017812 hasLocation W11200178123 @default.
• W1120017812 hasLocation W11200178124 @default.
• W1120017812 hasOpenAccess W1120017812 @default.
• W1120017812 hasPrimaryLocation W11200178121 @default.
• W1120017812 hasRelatedWork W161828712 @default.
• W1120017812 hasRelatedWork W2081339030 @default.
• W1120017812 hasRelatedWork W2083513729 @default.

• next